Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.
Identifieur interne : 002C51 ( PubMed/Curation ); précédent : 002C50; suivant : 002C52Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.
Auteurs : Kerri M. Clough-Gorr [États-Unis] ; Patricia A. Ganz ; Rebecca A. SillimanSource :
- The breast journal [ 1524-4741 ]
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Tumeurs du sein.
- mortalité : Tumeurs du sein.
- étiologie : Lymphoedème.
- Femelle, Humains, Santé mentale, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Survivants, Tumeurs du sein, Études de suivi, Études longitudinales.
English descriptors
- KwdEn :
- MESH :
- complications : Breast Neoplasms.
- etiology : Lymphedema.
- mortality : Breast Neoplasms.
- pathology : Breast Neoplasms.
- Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Longitudinal Studies, Mental Health, Neoplasm Staging, Survivors.
Abstract
Lymphedema of the arm is a common complication of breast cancer with symptoms that can persist over long periods of time. For older women (over 50% of breast cancer cases) it means living with the potential for long-term complications of persistent lymphedema in conjunction with the common diseases and disabilities of aging over survivorship. We identified women > or =65 years diagnosed with primary stage I-IIIA breast cancer. Data were collected over 7 years of follow-up from consenting patients' medical records and telephone interviews. Data collected included self-reported symptoms of persistent lymphedema, breast cancer characteristics, and selected sociodemographic and health-related characteristics. The overall prevalence of symptoms of persistent lymphedema was 36% over 7 years of follow-up. Having stage II or III (OR = 1.77, 95% CI: 1.07-2.93) breast cancer and having a BMI >30 (OR = 3.04, 95% CI: 1.69-5.45) were statistically significantly predictive of symptoms of persistent lymphedema. Women > or =80 years were less likely to report symptoms of persistent lymphedema when compared to younger women (OR = 0.44, 95% CI: 0.18-0.95). Women with symptoms of persistent lymphedema consistently reported worse general mental health and physical function. Symptoms of persistent lymphedema were common in this population of older breast cancer survivors and had a noticeable effect on both physical function and general mental health. Our findings provide evidence of the impact of symptoms of persistent lymphedema on the quality of survivorship of older women. Clinical and research efforts focused on risk factors for symptoms of persistent lymphedema in older breast cancer survivors may lead to preventative and therapeutic measures that help maintain their health and well-being over increasing periods of survivorship.
DOI: 10.1111/j.1524-4741.2009.00878.x
PubMed: 19968661
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002C51
Links to Exploration step
pubmed:19968661Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.</title><author><name sortKey="Clough Gorr, Kerri M" sort="Clough Gorr, Kerri M" uniqKey="Clough Gorr K" first="Kerri M" last="Clough-Gorr">Kerri M. Clough-Gorr</name><affiliation wicri:level="1"><nlm:affiliation>Geriatrics Section, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, USA. kmclough@bu.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Geriatrics Section, Boston University Schools of Medicine and Public Health, Boston, Massachusetts</wicri:regionArea></affiliation></author><author><name sortKey="Ganz, Patricia A" sort="Ganz, Patricia A" uniqKey="Ganz P" first="Patricia A" last="Ganz">Patricia A. Ganz</name></author><author><name sortKey="Silliman, Rebecca A" sort="Silliman, Rebecca A" uniqKey="Silliman R" first="Rebecca A" last="Silliman">Rebecca A. Silliman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2010 Mar-Apr</MedlineDate></PubDate></date><idno type="RBID">pubmed:19968661</idno><idno type="pmid">19968661</idno><idno type="doi">10.1111/j.1524-4741.2009.00878.x</idno><idno type="wicri:Area/PubMed/Corpus">002C51</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C51</idno><idno type="wicri:Area/PubMed/Curation">002C51</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C51</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.</title><author><name sortKey="Clough Gorr, Kerri M" sort="Clough Gorr, Kerri M" uniqKey="Clough Gorr K" first="Kerri M" last="Clough-Gorr">Kerri M. Clough-Gorr</name><affiliation wicri:level="1"><nlm:affiliation>Geriatrics Section, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, USA. kmclough@bu.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Geriatrics Section, Boston University Schools of Medicine and Public Health, Boston, Massachusetts</wicri:regionArea></affiliation></author><author><name sortKey="Ganz, Patricia A" sort="Ganz, Patricia A" uniqKey="Ganz P" first="Patricia A" last="Ganz">Patricia A. Ganz</name></author><author><name sortKey="Silliman, Rebecca A" sort="Silliman, Rebecca A" uniqKey="Silliman R" first="Rebecca A" last="Silliman">Rebecca A. Silliman</name></author></analytic><series><title level="j">The breast journal</title><idno type="eISSN">1524-4741</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (mortality)</term><term>Breast Neoplasms (pathology)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Longitudinal Studies</term><term>Lymphedema (etiology)</term><term>Mental Health</term><term>Neoplasm Staging</term><term>Survivors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Lymphoedème (étiologie)</term><term>Santé mentale</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survivants</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (mortalité)</term><term>Études de suivi</term><term>Études longitudinales</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Longitudinal Studies</term><term>Mental Health</term><term>Neoplasm Staging</term><term>Survivors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Santé mentale</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survivants</term><term>Tumeurs du sein</term><term>Études de suivi</term><term>Études longitudinales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema of the arm is a common complication of breast cancer with symptoms that can persist over long periods of time. For older women (over 50% of breast cancer cases) it means living with the potential for long-term complications of persistent lymphedema in conjunction with the common diseases and disabilities of aging over survivorship. We identified women > or =65 years diagnosed with primary stage I-IIIA breast cancer. Data were collected over 7 years of follow-up from consenting patients' medical records and telephone interviews. Data collected included self-reported symptoms of persistent lymphedema, breast cancer characteristics, and selected sociodemographic and health-related characteristics. The overall prevalence of symptoms of persistent lymphedema was 36% over 7 years of follow-up. Having stage II or III (OR = 1.77, 95% CI: 1.07-2.93) breast cancer and having a BMI >30 (OR = 3.04, 95% CI: 1.69-5.45) were statistically significantly predictive of symptoms of persistent lymphedema. Women > or =80 years were less likely to report symptoms of persistent lymphedema when compared to younger women (OR = 0.44, 95% CI: 0.18-0.95). Women with symptoms of persistent lymphedema consistently reported worse general mental health and physical function. Symptoms of persistent lymphedema were common in this population of older breast cancer survivors and had a noticeable effect on both physical function and general mental health. Our findings provide evidence of the impact of symptoms of persistent lymphedema on the quality of survivorship of older women. Clinical and research efforts focused on risk factors for symptoms of persistent lymphedema in older breast cancer survivors may lead to preventative and therapeutic measures that help maintain their health and well-being over increasing periods of survivorship.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19968661</PMID><DateCreated><Year>2010</Year><Month>05</Month><Day>14</Day></DateCreated><DateCompleted><Year>2010</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4741</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><MedlineDate>2010 Mar-Apr</MedlineDate></PubDate></JournalIssue><Title>The breast journal</Title><ISOAbbreviation>Breast J</ISOAbbreviation></Journal><ArticleTitle>Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.</ArticleTitle><Pagination><MedlinePgn>147-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1524-4741.2009.00878.x</ELocationID><Abstract><AbstractText>Lymphedema of the arm is a common complication of breast cancer with symptoms that can persist over long periods of time. For older women (over 50% of breast cancer cases) it means living with the potential for long-term complications of persistent lymphedema in conjunction with the common diseases and disabilities of aging over survivorship. We identified women > or =65 years diagnosed with primary stage I-IIIA breast cancer. Data were collected over 7 years of follow-up from consenting patients' medical records and telephone interviews. Data collected included self-reported symptoms of persistent lymphedema, breast cancer characteristics, and selected sociodemographic and health-related characteristics. The overall prevalence of symptoms of persistent lymphedema was 36% over 7 years of follow-up. Having stage II or III (OR = 1.77, 95% CI: 1.07-2.93) breast cancer and having a BMI >30 (OR = 3.04, 95% CI: 1.69-5.45) were statistically significantly predictive of symptoms of persistent lymphedema. Women > or =80 years were less likely to report symptoms of persistent lymphedema when compared to younger women (OR = 0.44, 95% CI: 0.18-0.95). Women with symptoms of persistent lymphedema consistently reported worse general mental health and physical function. Symptoms of persistent lymphedema were common in this population of older breast cancer survivors and had a noticeable effect on both physical function and general mental health. Our findings provide evidence of the impact of symptoms of persistent lymphedema on the quality of survivorship of older women. Clinical and research efforts focused on risk factors for symptoms of persistent lymphedema in older breast cancer survivors may lead to preventative and therapeutic measures that help maintain their health and well-being over increasing periods of survivorship.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clough-Gorr</LastName><ForeName>Kerri M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Geriatrics Section, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, USA. kmclough@bu.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganz</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Silliman</LastName><ForeName>Rebecca A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA106979</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA106979-05</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA106979</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA84506</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K05 CA092395</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA084506</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA/AG 70818</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA084506-04</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Breast J</MedlineTA><NlmUniqueID>9505539</NlmUniqueID><ISSNLinking>1075-122X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Feb;16(2):501-14</RefSource><PMID Version="1">9469334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2000 Nov;6(6):373-378</RefSource><PMID Version="1">11348395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2007;46(8):1138-42</RefSource><PMID Version="1">17851861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2002 Feb;11(1):81-7</RefSource><PMID Version="1">14965650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Jan 17;93(2):96-111</RefSource><PMID Version="1">11208879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2006 Oct;15(5):620-8</RefSource><PMID Version="1">16513350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2004 Jan;187(1):69-72</RefSource><PMID Version="1">14706589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2006 Nov-Dec;12(6):536-43</RefSource><PMID Version="1">17238983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phys Ther. 2001 Jun;81(6):1192-205</RefSource><PMID Version="1">11380275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2000 Sep-Oct;50(5):292-307; quiz 308-11</RefSource><PMID Version="1">11075239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2006 Feb;95(3):279-93</RefSource><PMID Version="1">16163445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Gynecol Obstet. 1974 Mar;138(3):370-6</RefSource><PMID Version="1">4811322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource><PMID Version="1">14639083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Gynecol Obstet. 1992 Nov;175(5):455-60</RefSource><PMID Version="1">1440176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2004 Jun;15(6):850-1</RefSource><PMID Version="1">15151938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Nov 10;24(32):5105-11</RefSource><PMID Version="1">17093271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Aug 15;83(4):706-11</RefSource><PMID Version="1">9708934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Jan 15;19(2):322-8</RefSource><PMID Version="1">11208822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1993 Dec 1;72(11):3248-52</RefSource><PMID Version="1">8242549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 1996 Dec;12(6):376-9</RefSource><PMID Version="1">8973048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2004 Sep-Oct;10(5):405-11</RefSource><PMID Version="1">15327493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Care. 1993 Feb;31(2):141-54</RefSource><PMID Version="1">8433577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Care. 1992 Jun;30(6):473-83</RefSource><PMID Version="1">1593914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Phys Med Rehabil. 1996 Mar;77(3 Suppl):S74-80</RefSource><PMID Version="1">8599548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2007 Oct 15;110(8):1868-74</RefSource><PMID Version="1">17823909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gerontol Nurs. 2005 May;31(5):29-39</RefSource><PMID Version="1">15916201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Oncol. 2006 Nov;15(3):153-65</RefSource><PMID Version="1">17187979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1993 Aug;11(8):1536-44</RefSource><PMID Version="1">8336192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Apr 10;25(11):1334-40</RefSource><PMID Version="1">17312327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Plast Reconstr Surg Hand Surg. 1992;26(2):223-7</RefSource><PMID Version="1">1411352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1999 Mar;177(3):184-7; discussion 188</RefSource><PMID Version="1">10219851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775-82</RefSource><PMID Version="1">17416770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2001 Dec;10(6):515-22</RefSource><PMID Version="1">14965632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Jun 1;20(11):2680-8</RefSource><PMID Version="1">12039930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mayo Clin Proc. 2005 Nov;80(11):1480-4</RefSource><PMID Version="1">16295027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2003 Aug 15;98(4):679-89</RefSource><PMID Version="1">12910510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull Cancer. 2006 Oct;93(10):1001-6</RefSource><PMID Version="1">17074659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 1996;38(2):183-99</RefSource><PMID Version="1">8861837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1997 Oct 1;80(7):1326-34</RefSource><PMID Version="1">9317187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Surg. 1993 Aug;36(4):315-20</RefSource><PMID Version="1">8370012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 1997 Jun;24(5):875-82</RefSource><PMID Version="1">9201739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Feb;16(2):487-94</RefSource><PMID Version="1">9469332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Nurs. 1995 Dec;18(6):467-71</RefSource><PMID Version="1">8564943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2002 Jun;35(2):59-71</RefSource><PMID Version="1">12081053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Nurs. 2005 May-Jun;28(3):200-7; quiz 208-9</RefSource><PMID Version="1">15915063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Aug 20;23(24):5458-60</RefSource><PMID Version="1">16043826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Oct 15;20(20):4242-8</RefSource><PMID Version="1">12377968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource><PMID Version="1">11745212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76</RefSource><PMID Version="1">14519753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2004 Jun;37(2):73-91</RefSource><PMID Version="1">15328760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Jul;110(2):337-42</RefSource><PMID Version="1">17851756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2775-890</RefSource><PMID Version="1">9925418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiology. 1991 Jul;180(1):177-84</RefSource><PMID Version="1">2052688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Feb 10;26(5):759-67</RefSource><PMID Version="1">18258984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2005 Sep-Oct;11(5):370-1</RefSource><PMID Version="1">16174167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Surg. 1999 Oct;65(10):995-8</RefSource><PMID Version="1">10515551</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS159912</OtherID><OtherID Source="NLM">PMC2873157</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19968661</ArticleId><ArticleId IdType="pii">TBJ878</ArticleId><ArticleId IdType="doi">10.1111/j.1524-4741.2009.00878.x</ArticleId><ArticleId IdType="pmc">PMC2873157</ArticleId><ArticleId IdType="mid">NIHMS159912</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002C51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:19968661
|texte= Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19968661" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |